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cardiomyocyte hypertrophy is unknown. Previous study demon-
strated that peroxisomal proliferator-activated receptor (PPAR)-α
ligand (fenoﬁbrate) prevents ET-1-induced cardiomyocyte hyper-
trophy. Though EPA is a ligand of PPAR-α, there was no study linking
relationship between EPA and PPAR-α in the ﬁeld of cardiomyocyte
hypertrophy. The present study investigated whether ET-1-induced
cardiomyocyte hypertrophy could be prevented by EPA pre-treatment
with possible mechanistic insights. At day 4 of culture, neonatal rat
cardiomyocytes were divided into three groups: control, ET-1 (0.1 nM)
treated and EPA-pre-treated (10 μM) ET-1 groups. 2-fold increase in
cardiomyocyte surface area, 1.8-fold increase in total protein synthesis
rate and an enhanced α-actinin expression in cardiomyocyte were
observed after ET-1 administration and these changes were greatly
prevented by EPA pre-treatment. ET-1-induced hypertrophied cardio-
myocytes showed increases in ANP and BNP mRNA expression, which
were also suppressed by EPA pre-treatment. Pre-treatment of EPA could
also attenuate phosphorylated JNK (an important component of MAPK
cascade) and c-Jun (downstream molecules of JNK) in ET-1-induced
hypertrophied cardiomyocytes. PPAR-α expression and PPAR-PPRE
binding activity were suppressed in ET-1 administered cardiomyocyte
and this suppressionwas improvedbyEPA treatment. In conclusion, the
present study showed that ET-1 could induce signiﬁcant cardiomyocyte
hypertrophy with hypertrophic markers upregulation, and that this
remodeling was effectively prevented by EPA-pre-administration
through the upregulation of PPAR-α and the suppression of phosphor-
ylated JNK, and c-Jun.
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Objective: Endothelins are powerful vasoconstrictor peptides that
also play numerous other functions in many different organs.
Endothelin-1 (ET-1) is the most abundant and important of this
family of peptides in blood vessels. ET-1, a potential marker of
endothelial dysfunction has been shown in hypertensive subjects. No
study yet has investigated the circulatory level of ET-1 in a country
from South Asia. The present study assessed circulating levels of ET-1
in subjects with or without hypertension and further examined
their association with clinical and metabolic parameters. Methods
and results: A total of 1802 rural Bangladeshi women with mean age
of 44.16 yearswere studiedusing a cross-sectional survey. Theprevalence
of hypertension was 31.78%. Endothelin-1 levels were signiﬁcantly
higher in hypertensive than in non-hypertensive subjects (hypertensive
vs non-hypertensive: 4.16 ± 0.32 vs. 3.00 ± 0.08 pg/ml, p b 0.001). After
adjusting for age, ET-1 had signiﬁcant positive associations with diastolic
blood pressure (DBP) (β=0.039, p = 0.013) and systolic blood pressure
(SBP) (β=0.020, p = 0.006). Unlike blood pressures, other variables
including insulin, fasting blood glucose, triglycerides, high-density
lipoprotein cholesterol, body mass index, waist circumference and
vascular endothelial growth factor were not associated with ET-1.
Stepwise multiple regression analysis, after adjusting for age and all
other potential variables revealed that SBP and DBP were independent
determinants of ET-1. Conclusions: The correlation of ET-1 needs
further investigations to deﬁne the clinical utility and predictive value
of serumET-1 levels in hypertension for South Asian population. Higher
concentration of ET-1 suggests endothelial dysfunction already in mild
forms of hypertension without further risk factors or cardiovascular
complications in this apparently healthy population.
doi:10.1016/j.lfs.2014.01.017
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Patients with ASD have increased pulmonary blood ﬂow and may
cause increase in pulmonary arterial pressure. Endothelin-1 (ET-1)
mainly produced by pulmonary vascular endothelium and increased
plasma ET-1 level has been reported in patients with left-to-right
shunt. ASD is the most common congenital shunting in adult.
However, no study addressed speciﬁcally for ASD and has evaluated
the role of ET-1 in this congenital shunting. Therefore, we aim to
correlate the peripheral ET-1 level with pulmonary arterial pressure in
adult patients with uncorrected ASD. From July 2012–April 2013 we
enrolled 55 ASD patients; mean age 34.5 years-old. Conﬁrmation of
ASD and the measurement for pulmonary arterial pressure (mPAP),
right ventricular systolic pressure (RVSP), and pulmonary ﬂow ratio
(Qp/Qs) were performed using TTE and TEE. These measure-
ments were previously conﬁrmed with right heart cathetherization
and showed positive correlation (r = 0.5; p b 0.0001 and r = 0.8;
p b 0.0001 respectively). Peripheral blood was withdrawn from
brachial vein. Forty (72%) patients have left-to-right and 28% with
right-to-left shunting. Mean mPAP was 40.1 ± 14.9 mm Hg; mean
circulating ET-1 was 5.6 ± 2.1 pg/dl. Unexpectedly, the correlation
between circulating level of ET-1 andmPAPwas signiﬁcantly inversed
(r = -0.452;p b 0.01), and with RVSP was also signiﬁcantly negative
(r = -0.405;p b 0.01). Accordingly, the reduced circulating ET-1 level
might be explained by the decrease in Qp/Qs (r = 0.310;p b 0.05).
However, no differences of ET-1 were found between LtoR vs
RtoL shunts (5.7 ± 0.36vs.5.3 ± 0.52 pg/dl; NS). As a conclusion, we
observed inversed relationship between circulating ET-1 and
mPAP that might partially be explained by the decreased in pulmonary
ﬂow. Further study to elucidate whether pulmonary derived ET-1 may
play more roles in this disease is needed.
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